AccurEdit Therapeutics News and Activities

Acquisition, funding and merger involving AccurEdit Therapeutics.

• AccurEdit Therapeutics has just announced a $75 Million fundraising (posted on February 4 2026).

View the org chart displaying its 2 main executives

Most searched biographies at AccurEdit Therapeutics

• Yongzhong Wang, Chief Executive Officer and Chairman of the Board
• Jialin Tao, Head of Research

Create your alert
to follow the executive moves at AccurEdit Therapeutics.

AccurEdit Therapeutics has 2,405 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and BioNTech (Germany).

Popular M&A news in Biotechnology

• Laboratoire Servier has announced the acquisition of Edgewise Therapeutics  (posted on June 4 2026).
• Oak Hill Bio has just announced a $33 Million fundraising (posted on June 4 2026).
• IMU Biosciences has just announced a $53 Million fundraising (posted on June 3 2026).

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Jan Van de Winkel - President and Chief Executive Officer at Genmab
• Valerie Hanote - Non-Executive Director at Eurofins

Learn more about the Biotechnology industry

Press releases by AccurEdit Therapeutics

Social media about AccurEdit Therapeutics

• AccurEdit Therapeutics on Wikipedia, Google News & Yahoo Finance
• AccurEdit Therapeutics on LinkedIn, X (Twitter) & YouTube